GALW/CMNHS1218/2025 - Clinical Trials Services Establishment of DPS for the delivery of Clinical Trial Service in 2 Lots

CMNHS246/2026- Establishment of a Single Operator Framework Agreement For Qualified Person (QP) Services to CCMI for the University of Galway

The University of Galway needs Qualified Person (QP) services for a framework agreement over 4 months, with a maximum total value of 300,000 EUR. The services involve reviewing batch documentation for ATMP Products manufactured at The Centre for Cell Manufacturing Ireland (CCMI) and releasing these products for clinical trial patients in accordance with relevant requirements. The services are to be delivered in the West of Ireland.

LA3739DPS - Request for Applications to Participate in a Dynamic Purchasing System for Genomics, Sequencing and Molecular Services to the Irish Public Sector

LA3739DPS - Request for Applications to Participate in a Dynamic Purchasing System for Genomics, Sequencing and Molecular Services to the Irish Public Sector . The DPS will comprise of 6 lots.

HSE 21101 Dynamic Purchasing System (DPS) Invitation for Enteral Nutrition Products and Related Devices

Health Service Executive (HSE) needs enteral nutrition products and related devices for a maximum total value of 210,000,000 EUR over 7 years.

GALW/COSE1847/26 Conducting technical and pre-clinical research and development of a novel cardiovascular medical device.

The University of Galway needs services for conducting technical and pre-clinical research and development of a novel cardiovascular medical device through a framework agreement over 4 years, with a maximum total value of 350,000 EUR. The procurement is divided into two lots: Lot 1 for an R&D Consultant to develop the medical device for pre-clinical study, and Lot 2 for the evaluation of the device in a large animal model, including protocol development, study strategy, and implanting prototype devices in acute animals for proof of concept and assessment.

2026-082 - GDMSAD01 - Système d'Acquisition Dynamique pour la fourniture de Dispositifs Médicaux Stériles pour le compte des établissements adhérents du GCS Pharma Hauts de France

Le Centre Hospitalier de Lens a besoin de dispositifs médicaux stériles pour le compte des établissements adhérents du GCS Pharma Hauts de France, pour une durée de 10 ans, avec une valeur maximale estimée à 800 millions d'euros.